Abstract
Introduction
Arthroplasties of hip and knee are associated with blood loss, which may lead to adverse patient outcome. Performing arthroplasties in Jehovah’s Witness patients who do not accept transfusion has been a matter of concern. We developed a protocol, which avoids transfusion in arthroplasties of Jehovah’s Witness patients, and evaluated the feasibility and safety of the protocol.
Materials and methods
The target of preoperative hemoglobin was more than 10 g/dL. When preoperative hemoglobin was lower than 10 g/dL, 4000 U erythropoietin (3 times a week) and 100 mg iron supplement (every day) were administered until the hemoglobin reached 10 g/dL. When the preoperative hemoglobin was higher than 10 g/dL, 4000 U erythropoietin and 100 mg iron supplement were administered once, before operation. During the operation, cell saver was used. Postoperatively, erythropoietin and iron supplements were administered until the hemoglobin reached 10 g/dL, similar to the preoperative protocol. We evaluated the feasibility of our protocol, perioperative complications and hematologic changes.
Results
From 2002 to 2014, 186 Witness patients visited our department. In 179 patients (96.2 %), 77 total knee arthroplasties, 69 bipolar hemiarthroplasties and 33 total hip arthroplasties were performed. The mean hemoglobin level was 12.3 g/dL preoperatively, 9.4 g/dL on postoperative day 3 and 10.3 g/dL on postoperative day 7. One patient died immediately after the arthroplasty and the remaining 178 patients survived.
Conclusions
Total joint arthroplasty could be done without transfusion using this protocol in most of our patients. The rates of infection and mortality were similar with known infection and mortality rates of arthroplasties. In patients who do not want allogeneic transfusions, our protocol is a safe alternative to perform joint arthroplasties.
This is a preview of subscription content, access via your institution.





References
Newman ET, Watters TS, Lewis JS, Jennings JM, Wellman SS, Attarian DE, Grant SA, Green CL, Vail TP, Bolognesi MP (2014) Impact of perioperative allogeneic and autologous blood transfusion on acute wound infection following total knee and total hip arthroplasty. J Bone Jt Surg Am 96(4):279–284. doi:10.2106/JBJS.L.01041
Friedman R, Homering M, Holberg G, Berkowitz SD (2014) Allogeneic blood transfusions and postoperative infections after total hip or knee arthroplasty. J Bone Jt Surg Am 96(4):272–278. doi:10.2106/JBJS.L.01268
Watts CD, Pagnano MW (2012) Minimising blood loss and transfusion in contemporary hip and knee arthroplasty. J Bone Jt Surg Br 94(11 Suppl A):8–10. doi:10.1302/0301-620X.94B11.30618
Shemshaki H, Nourian SM, Nourian N, Dehghani M, Mokhtari M, Mazoochian F (2015) One step closer to sparing total blood loss and transfusion rate in total knee arthroplasty: a meta-analysis of different methods of tranexamic acid administration. Arch Orthop Trauma Surg 135(4):573–588. doi:10.1007/s00402-015-2189-7
Li N, Li P, Liu M, Wang D, Xia L (2014) Comparison between autologous blood transfusion drainage and no drainage/closed-suction drainage in primary total hip arthroplasty: a meta-analysis. Arch Orthop Trauma Surg 134(11):1623–1631. doi:10.1007/s00402-014-2090-9
Mahringer-Kunz A, Efe T, Fuchs-Winkelmann S, Schuttler KF, Paletta JR, Heyse TJ (2015) Bleeding in TKA: posterior stabilized vs. cruciate retaining. Arch Orthop Trauma Surg 135(6):867–870. doi:10.1007/s00402-015-2209-7
Jauregui JJ, Kapadia BH, Banerjee S, Issa K, Su S, Harwin SF, Mont MA (2014) Blood management strategies for total hip arthroplasty in Jehovah’s Witness patients. Surg Technol Int 24:338–343
Park JH, Rasouli MR, Mortazavi SM, Tokarski AT, Maltenfort MG, Parvizi J (2013) Predictors of perioperative blood loss in total joint arthroplasty. J Bone Jt Surg Am 95(19):1777–1783. doi:10.2106/JBJS.L.01335
Browne JA, Adib F, Brown TE, Novicoff WM (2013) Transfusion rates are increasing following total hip arthroplasty: risk factors and outcomes. J Arthroplast 28(8 Suppl):34–37. doi:10.1016/j.arth.2013.03.035
Yoshihara H, Yoneoka D (2014) Predictors of allogeneic blood transfusion in total hip and knee arthroplasty in the United States, 2000-2009. J Arthroplast. doi:10.1016/j.arth.2014.04.026
Aguilera X, Martinez-Zapata MJ, Hinarejos P, Jordan M, Leal J, Gonzalez JC, Monllau JC, Celaya F, Rodriguez-Arias A, Fernandez JA, Pelfort X, Puig-Verdie L (2015) Topical and intravenous tranexamic acid reduce blood loss compared to routine hemostasis in total knee arthroplasty: a multicenter, randomized, controlled trial. Arch Orthop Trauma Surg 135(7):1017–1025. doi:10.1007/s00402-015-2232-8
Yi S, Tan J, Chen C, Chen H, Huang W (2014) The use of pneumatic tourniquet in total knee arthroplasty: a meta-analysis. Arch Orthop Trauma Surg 134(10):1469–1476. doi:10.1007/s00402-014-2056-y
Sabatini L, Atzori F, Revello S, Scotti L, Debiasi F, Masse A (2014) Intravenous use of tranexamic acid reduces postoperative blood loss in total knee arthroplasty. Arch Orthop Trauma Surg 134(11):1609–1614. doi:10.1007/s00402-014-2081-x
Ogbemudia AE, Yee SY, MacPherson GJ, Manson LM, Breusch SJ (2013) Preoperative predictors for allogenic blood transfusion in hip and knee arthroplasty for rheumatoid arthritis. Arch Orthop Trauma Surg 133(9):1315–1320. doi:10.1007/s00402-013-1784-8
Park KH, Lee SR, Jin JM, Moon MS (2012) The efficacy and safety of postoperative autologous transfusion of filtered shed blood and anticoagulant prophylaxis in total knee arthroplasty patients. Knee Surg Relat Res 24(1):14–18. doi:10.5792/ksrr.2012.24.1.14
Toy PT, Kaplan EB, McVay PA, Lee SJ, Strauss RG, Stehling LC (1992) Blood loss and replacement in total hip arthroplasty: a multicenter study. The Preoperative Autologous Blood Donation Study Group. Transfusion 32(1):63–67
Faris PM, Ritter MA (1998) Epoetin alfa. A bloodless approach for the treatment of perioperative anemia. Clin Orthop Relat Res 357:60–67
de Andrade JR, Jove M, Landon G, Frei D, Guilfoyle M, Young DC (1996) Baseline hemoglobin as a predictor of risk of transfusion and response to Epoetin alfa in orthopedic surgery patients. Am J Orthop (Belle Mead NJ) 25(8):533–542
Eschbach JW, Egrie JC, Downing MR, Browne JK, Adamson JW (1987) Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial. N Engl J Med 316(2):73–78. doi:10.1056/NEJM198701083160203
Winearls CG, Oliver DO, Pippard MJ, Reid C, Downing MR, Cotes PM (1986) Effect of human erythropoietin derived from recombinant DNA on the anaemia of patients maintained by chronic haemodialysis. Lancet 2(8517):1175–1178
Moskal JT, Harris RN, Capps SG (2015) Transfusion cost savings with tranexamic acid in primary total knee arthroplasty from 2009 to 2012. J Arthroplast 30(3):365–368. doi:10.1016/j.arth.2014.10.008
Harris RN, Moskal JT, Capps SG (2015) Does tranexamic acid reduce blood transfusion cost for primary total hip arthroplasty? A case-control study. J Arthroplasty 30(2):192–195. doi:10.1016/j.arth.2014.08.020
Byrne MP (1976) Abdominal aortic aneurysm surgery in the Jehovah’s Witness. Use of auto transfusion. IMJ Ill Med J 150(1):87–90
Takaori M, Kimura K, Endo E (1989) Anesthesia and preoperative hemodilution for autotransfusion. Masui 38(12):1627–1632
Bierbaum BE, Callaghan JJ, Galante JO, Rubash HE, Tooms RE, Welch RB (1999) An analysis of blood management in patients having a total hip or knee arthroplasty. J Bone Jt Surg Am 81(1):2–10
Faris PM, Spence RK, Larholt KM, Sampson AR, Frei D (1999) The predictive power of baseline hemoglobin for transfusion risk in surgery patients. Orthopedics 22(1 Suppl):s135–s140
Keating EM, Meding JB, Faris PM, Ritter MA (1998) Predictors of transfusion risk in elective knee surgery. Clin Orthop Relat Res 357:50–59
Borghi B, Pignotti E, Montebugnoli M, Bassi A, Corbascio M, de Simone N, Elmar K, Righi U, Laguardia AM, Bugamelli S, Cataldi F, Ranocchi R, Feoli MA, Bombardini T, Gargioni G, Franchini AG, Caroli GC (1997) Autotransfusion in major orthopaedic surgery: experience with 1785 patients. Br J Anaesth 79(5):662–664
Bould M, Freeman BJ, Pullyblank A, Newman JH (1998) Blood loss in sequential bilateral total knee arthroplasty. J Arthroplast 13(1):77–79
Woolson ST, Pottorff G (1993) Use of preoperatively deposited autologous blood for total knee replacement. Orthopedics 16(2):137–141 discussion 141–132
Monreal M, Lafoz E, Llamazares J, Roncales J, Roca J, Granero X (1996) Preoperative platelet count and postoperative blood loss in patients undergoing hip surgery: an inverse correlation. Haemostasis 26(3):164–169
Nelson CL, Bowen WS (1986) Total hip arthroplasty in Jehovah’s Witnesses without blood transfusion. J Bone Jt Surg Am 68(3):350–353
Nelson CL, Fontenot HJ, Flahiff C, Stewart J (1998) An algorithm to optimize perioperative blood management in surgery. Clin Orthop Relat Res 357:36–42
Nelson CL, Stewart JG (1999) Primary and revision total hip replacement in patients who are Jehovah’s Witnesses. Clin Orthop Relat Res 369:251–261
Feagan BG, Wong CJ, Kirkley A, Johnston DW, Smith FC, Whitsitt P, Wheeler SL, Lau CY (2000) Erythropoietin with iron supplementation to prevent allogeneic blood transfusion in total hip joint arthroplasty. A randomized, controlled trial. Ann Intern Med 133(11):845–854
Lotke PA, Faralli VJ, Orenstein EM, Ecker ML (1991) Blood loss after total knee replacement. Effects of tourniquet release and continuous passive motion. J Bone Jt Surg Am 73(7):1037–1040
Dixon JL, Smalley MG (1981) Jehovah’s Witnesses. The surgical/ethical challenge. JAMA 246(21):2471–2472
Bourantas KL, Xenakis TA, Hatzimichael EC, Kontogeorgakos V, Beris AE (2000) Peri-operative use of recombinant human erythropoietin in Jehovah’s Witnesses. Haematologica 85(4):444–445
Levy O, Martinowitz U, Oran A, Tauber C, Horoszowski H (1999) The use of fibrin tissue adhesive to reduce blood loss and the need for blood transfusion after total knee arthroplasty. A prospective, randomized, multicenter study. J Bone Jt Surg Am 81(11):1580–1588
Schmied H, Kurz A, Sessler DI, Kozek S, Reiter A (1996) Mild hypothermia increases blood loss and transfusion requirements during total hip arthroplasty. Lancet 347(8997):289–292
Klatsky AL, Armstrong MA, Poggi J (2000) Risk of pulmonary embolism and/or deep venous thrombosis in Asian-Americans. Am J Cardiol 85(11):1334–1337. doi:10.1016/S0002-9149(00)00766-9
White RH, Zhou H, Gage BF (2004) Effect of age on the incidence of venous thromboembolism after major surgery. J Thromb Haemost JTH 2(8):1327–1333. doi:10.1046/j.1538-7836.2004.00848.x
White RH, Zhou H, Murin S, Harvey D (2005) Effect of ethnicity and gender on the incidence of venous thromboembolism in a diverse population in California in 1996. Thromb Haemost 93(2):298–305. doi:10.1267/THRO05020298
Kang BJ, Lee YK, Kim HJ, Ha YC, Koo KH (2011) Deep venous thrombosis and pulmonary embolism are uncommon in East Asian patients after total hip arthroplasty. Clin Orthop Relat Res 469(12):3423–3428. doi:10.1007/s11999-011-1979-7
Zhang J, Chen Z, Zheng J, Breusch SJ, Tian J (2015) Risk factors for venous thromboembolism after total hip and total knee arthroplasty: a meta-analysis. Arch Orthop Trauma Surg 135(6):759–772. doi:10.1007/s00402-015-2208-8
Danninger T, Stundner O, Ma Y, Bae JJ, Memtsoudis SG (2013) The impact of hypotensive epidural anesthesia on distal and proximal tissue perfusion in patients undergoing total hip arthroplasty. J Anesth Clin Res 4(11):366. doi:10.4172/2155-6148.1000366
Westrich GH, Farrell C, Bono JV, Ranawat CS, Salvati EA, Sculco TP (1999) The incidence of venous thromboembolism after total hip arthroplasty: a specific hypotensive epidural anesthesia protocol. J Arthroplast 14(4):456–463
Park MS, Kim SJ, Chung CY, Choi IH, Lee SH, Lee KM (2010) Statistical consideration for bilateral cases in orthopaedic research. J Bone Jt Surg Am 92(8):1732–1737. doi:10.2106/JBJS.I.00724
Janssens M, Joris J, David JL, Lemaire R, Lamy M (1994) High-dose aprotinin reduces blood loss in patients undergoing total hip replacement surgery. Anesthesiology 80(1):23–29
Konishi A, Kikuchi A (1996) Advertisement of bloodless medicine: the role of the department of anesthesiology. Autotransfusion 9:17–19
Morais S, Ortega-Andreu M, Rodriguez-Merchan EC, Padilla-Eguiluz NG, Perez-Chrzanowska H, Figueredo-Zalve R, Gomez-Barrena E (2014) Blood transfusion after primary total knee arthroplasty can be significantly minimised through a multimodal blood-loss prevention approach. Int Orthop 38(2):347–354. doi:10.1007/s00264-013-2188-7
Horstmann WG, Swierstra MJ, Ohanis D, Rolink R, Kollen BJ, Verheyen CC (2014) Favourable results of a new intraoperative and postoperative filtered autologous blood re-transfusion system in total hip arthroplasty: a randomised controlled trial. Int Orthop 38(1):13–18. doi:10.1007/s00264-013-2084-1
Harwin SF, Pivec R, Naziri Q, Issa K, Mont MA (2014) Is total hip arthroplasty a successful and safe procedure in Jehovah’s Witnesses? Mean 5-year results. Hip Int 24(1):69–76. doi:10.5301/hipint.5000106
Issa K, Banerjee S, Rifai A, Kapadia BH, Harwin SF, McInerney VK, Mont MA (2013) Blood management strategies in primary and revision total knee arthroplasty for Jehovah’s Witness patients. J Knee Surg 26(6):401–404. doi:10.1055/s-0033-1353994
Harwin SF, Issa K, Naziri Q, Pivec R, Johnson AJ, Mont MA (2013) Excellent results of revision TKA in Jehovah’s Witness patients. J Knee Surg 26(3):151–154. doi:10.1055/s-0032-1324812
Harwin SF, Issa K, Naziri Q, Johnson AJ, Mont MA (2013) Results of primary total knee arthroplasty in Jehovah’s Witness patients. J Arthroplasty 28(1):49–55. doi:10.1016/j.arth.2012.05.021
Bernasek T, Mangar D, Omar HR, Lyons S, Karlnoski RA, Chen R, Baumgarten A, Sprenker CJ, Camporesi EM (2013) Bloodless surgery by a regional intraarterial tourniquet during primary and revision THA. Orthopedics 36(12):e1527–e1533
Harwin SF, Pivec R, Johnson AJ, Naziri Q, Mont MA (2012) Revision total hip arthroplasty in Jehovah’s Witnesses. Orthopedics 35(8):e1145–e1151. doi:10.3928/01477447-20120725-11
Barsoum WK, Klika AK, Murray TG, Higuera C, Lee HH, Krebs VE (2011) Prospective randomized evaluation of the need for blood transfusion during primary total hip arthroplasty with use of a bipolar sealer. J Bone Jt Surg Am 93(6):513–518. doi:10.2106/JBJS.J.00036
Rosenberg AG (2007) Reducing blood loss in total joint surgery with a saline-coupled bipolar sealing technology. J Arthroplast 22(4 Suppl 1):82–85. doi:10.1016/j.arth.2007.02.018
de Castro Araujo BL (2013) Use of perioperative erythropoietin without pharmacologic thrombosis prophylaxis. Orthopedics 36(2):89. doi:10.3928/01477447-20130122-11
Moonen AF, Thomassen BJ, Knoors NT, van Os JJ, Verburg AD, Pilot P (2008) Pre-operative injections of epoetin-alpha versus post-operative retransfusion of autologous shed blood in total hip and knee replacement: a prospective randomised clinical trial. J Bone Jt Surg Br 90(8):1079–1083. doi:10.1302/0301-620X.90B8.20595
Ng T, Marx G, Littlewood T, Macdougall I (2003) Recombinant erythropoietin in clinical practice. Postgrad Med J 79(933):367–376
Silva M, Grillot D, Benito A, Richard C, Nunez G, Fernandez-Luna JL (1996) Erythropoietin can promote erythroid progenitor survival by repressing apoptosis through Bcl-XL and Bcl-2. Blood 88(5):1576–1582
Huraib S, Abu-Aisha H, Al-Momen A, Al-Wakeel J, Memon N, Al-Tuwaijri A (1997) Effect of recombinant human erythropoietin on lymphocyte phenotyping and phagocyte activity in hemodialysis patients. Am J Kidney Dis 29(6):866–870
Tilbrook PA, Klinken SP (1999) The erythropoietin receptor. Int J Biochem Cell Biol 31(10):1001–1005
Weber EW, Slappendel R, Hemon Y, Mahler S, Dalen T, Rouwet E, van Os J, Vosmaer A, van der Ark P (2005) Effects of epoetin alfa on blood transfusions and postoperative recovery in orthopaedic surgery: the European Epoetin Alfa Surgery Trial (EEST). Eur J Anaesthesiol 22(4):249–257
Sutton PM, Cresswell T, Livesey JP, Speed K, Bagga T (2004) Treatment of anaemia after joint replacement. A double-blind, randomised, controlled trial of ferrous sulphate versus placebo. J Bone Jt Surg Br 86(1):31–33
Munoz M, Gomez-Ramirez S, Martin-Montanez E, Naveira E, Seara J, Pavia J (2014) Cost of post-operative intravenous iron therapy in total lower limb arthroplasty: a retrospective, matched cohort study. Blood Transfus (Trasfusione del sangue) 12(1):40–49. doi:10.2450/2013.0088-13
Munoz M, Gomez-Ramirez S, Cuenca J, Garcia-Erce JA, Iglesias-Aparicio D, Haman-Alcober S, Ariza D, Naveira E (2014) Very-short-term perioperative intravenous iron administration and postoperative outcome in major orthopedic surgery: a pooled analysis of observational data from 2547 patients. Transfusion 54(2):289–299. doi:10.1111/trf.12195
Kapadia BH, Banerjee S, Issa K, McElroy MJ, Harwin SF, Mont MA (2013) Preoperative blood management strategies for total knee arthroplasty. J Knee Surg 26(6):373–377. doi:10.1055/s-0033-1357492
Enko D, Wallner F, von-Goedecke A, Hirschmugl C, Auersperg V, Halwachs-Baumann G (2013) The impact of an algorithm-guided management of preoperative anemia in perioperative hemoglobin level and transfusion of major orthopedic surgery patients. Anemia 2013:641876. doi:10.1155/2013/641876
Munoz M, Naveira E, Seara J, Cordero J (2012) Effects of postoperative intravenous iron on transfusion requirements after lower limb arthroplasty. Br J Anaesth 108(3):532–534. doi:10.1093/bja/aes012
Yang Y, Li H, Li B, Wang Y, Jiang S, Jiang L (2011) Efficacy and safety of iron supplementation for the elderly patients undergoing hip or knee surgery: a meta-analysis of randomized controlled trials. J Surg Res 171(2):e201–e207. doi:10.1016/j.jss.2011.08.025
Na HS, Shin SY, Hwang JY, Jeon YT, Kim CS, Do SH (2011) Effects of intravenous iron combined with low-dose recombinant human erythropoietin on transfusion requirements in iron-deficient patients undergoing bilateral total knee replacement arthroplasty. Transfusion 51(1):118–124. doi:10.1111/j.1537-2995.2010.02783.x
Cuenca J, Garcia-Erce JA, Martinez F, Perez-Serrano L, Herrera A, Munoz M (2006) Perioperative intravenous iron, with or without erythropoietin, plus restrictive transfusion protocol reduce the need for allogeneic blood after knee replacement surgery. Transfusion 46(7):1112–1119. doi:10.1111/j.1537-2995.2006.00859.x
Cuenca J, Garcia-Erce JA, Martinez AA, Solano VM, Molina J, Munoz M (2005) Role of parenteral iron in the management of anaemia in the elderly patient undergoing displaced subcapital hip fracture repair: preliminary data. Arch Orthop Trauma Surg 125(5):342–347. doi:10.1007/s00402-005-0809-3
Acknowledgments
This work was supported by the Soonchunhyang University Research Fund.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
No benefits in any form have been received or will be received from a commercial party related directly or indirectly to the subject of this article.
Rights and permissions
About this article
Cite this article
Suh, YS., Nho, JH., Choi, HS. et al. A protocol avoiding allogeneic transfusion in joint arthroplasties. Arch Orthop Trauma Surg 136, 1213–1226 (2016). https://doi.org/10.1007/s00402-016-2516-7
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00402-016-2516-7
Keywords
- Transfusion
- Arthroplasty
- Hip
- Knee